|

Pioglitazone 30 mg Clinical Trials

3 actively recruiting trials across 1 location

No change since May 2026

Also known as: Actos, BR3006B

Pipeline

Phase 1: 2Phase 2: 1

Top Sponsors

  • Boryung Pharmaceutical Co., Ltd2
  • West Virginia University1

Indications

Other2 trials

A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fasting)
Phase 1
A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fed)
Phase 1

Morgantown, West Virginia1 trial

Pioglitazone Therapy Targeting Fatigue in Breast Cancer

West Virginia University Cancer Institute

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.